SCHEMBL2860093

SCHEMBL2860093

O=C(O)c1ccc2[nH]nc(-c3cccc(C(F)(F)F)c3)c2c1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP2K4 P45985 10/20 0.71
MAPK1 P28482 6/20 0.71
MAPK6 Q16659 6/20 0.71
MAPKAPK3 Q16644 4/20 0.71
MAPKAPK5 Q8IW41 1/20 0.60
IP6K1 Q92551 1/20 0.56
IP6K3 Q96PC2 1/20 0.56
IP6K2 Q9UHH9 1/20 0.56
PIM1 P11309 1/20 0.55
MAPKAPK2 P49137 1/20 0.52
PDPK1 O15530 1/20 0.52
MAP3K5 Q99683 2/20 0.51
LRRK2 Q5S007 1/20 0.49
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
KDM4E B2RXH2 1/20 0.47
ALDH1A1 P00352 1/20 0.47
SRD5A2 P31213 1/20 0.47
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22801797 0.83 MAP2K4 (1.00) MAP2K4MAPK1MAPK6MAPKAPK3MAPKAPK5
SCHEMBL2858476 0.83 MAP2K4 (0.68) MAP2K4MAPK1MAPK6MAPKAPK3MAPKAPK5
SCHEMBL2866791 0.82 MAP2K4 (0.69) MAP2K4MAPK1MAPK6MAPKAPK3MAPKAPK5
Ethylene SCHEMBL27536148 0.81 MAP2K4 (0.65) MAP2K4MAPK1MAPK6MAPKAPK3MAPKAPK5
SCHEMBL2861623 0.81 MAPK1 (0.63) MAP2K4MAPK1MAPK6MAPKAPK3
SCHEMBL2868589 0.80 MAP2K4 (0.69) MAP2K4MAPK1MAPK6MAPKAPK3MAPKAPK5
SCHEMBL2466587 0.79 PIM1 (0.56) MAP2K4MAPK1MAPK6MAPKAPK3PIM1
SCHEMBL22801693 0.79 MAP2K4 (0.76) MAP2K4MAPK1MAPK6MAPKAPK3MAPKAPK5
SCHEMBL17829665 0.78 AURKA (0.60) MAP2K4MAPK1MAPK6MAPKAPK3PIM1
SCHEMBL2868570 0.78 MAP2K4 (0.59) MAP2K4MAPK1MAPK6MAPKAPK3LRRK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
EP-1380576-B1 1H-INDAZOLE COMPOUNDS INHIBITING JNK EISAI R&D MAN CO LTD (JP) 2009-11-25 EP disclosed
EP-1380576-B1 1H-INDAZOLE COMPOUNDS INHIBITING JNK EISAI R&D MAN CO LTD (JP) 2009-11-25 EP disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-7541376-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-02 US disclosed
US-7541376-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-02 US disclosed
US-7541376-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-02 US disclosed
CN-1300116-C 1H-indazole compounds EISAI CO LTD (JP) 2007-02-14 CN disclosed
US-6982274-B2 1H-indazole compound EISAI CO., LTD. (JP) 2006-01-03 US disclosed
US-20050282880-A1 Novel 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-12-22 US disclosed
CN-1512987-A Novel 1H-indazole compound ������������ʽ���� 2004-07-14 CN disclosed
US-20040127538-A1 Novel 1h-indazole compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-07-01 US disclosed
EP-1380576-A1 NOVEL 1H-INDAZOLE COMPOUND Eisai Co., Ltd. (JP) 2004-01-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203691-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 MAP2K4 61/4885MAPK1 1/4885MAPK6 24/4885
US-20040127538-A1 Novel 1h-indazole compound MAPK1, MAPK14, MAPK3 MAP2K4 53/4885MAPK1 1/4885MAPK6 5/4885
US-20050282880-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 MAP2K4 61/4885MAPK1 1/4885MAPK6 24/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.